EFFECTIVENESS OF CONVENTIONAL VS. HYPO FRACTIONATED RT SCHEDULES FOR CHEST WALL IRRADIATION IN BREAST CANCER TREATMENT AND OUTCOME.

Koulis TA, Phan T, Olivotto IA. Hypofractionated whole breast radiotherapy: current perspectives. Breast Cancer (Dove Med Press) 2015;7:363-70.         

START Trialists’ Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet Oncology 2008;9(4):331-41.          

Noone AM Howlader N, Krapcho M, et al. SEER Cancer statistics review, 1975-2015, National Cancer Institute. Bethesda, MD, based on November 2017 SEER data submission, posted to the SEER web site, April 2018. https://seer.cancer.gov/csr/1975_2015/              

Gupta S. Breast cancer: Indian experience, data and evidence. South Asian Journal of Cancer 2016;5(3):85-6.             

Gradishar W, Salerno KE. NCCN Guidelines Update: Breast Cancer. Journal of the National Comprehensive Cancer Network JNCCN 2016;14(Suppl 5):641-4.              

Early Breast Cancer Trialists' Collaborative Group. Radiotherapy for early breast cancer. The Cochrane Database of Systematic Reviews 2002;(2):CD003647.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-717.      

Smith BD, Bellon JR, Blitzblau R, et al. Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Practical Radiation Oncology 2018;8(3):145-52.                              

START Trialists’ Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371(9618):1098-107.            

Plataniotis G. Hypofractionated radiotherapy in the treatment of early breast cancer. World Journal of Radiology 2010;2(6):197-202.                     

Pires AM, Segreto RA, Segreto HR. RTOG criteria to evaluate acute skin reaction and its risk factors in patients with breast cancer submitted to radiotherapy. Revista Latino-Americana De Enfermagem 2008;16(5):844-9.                                

Whelan TJ, Pignol JP, Levine MN, et al. Long-Term results of hypofractionated radiation therapy for breast cancer. New England Journal of Medicine 2010;362(6):513-20.  

Akl FMF, Khater A. Hypofractionated versus conventionally fractionated radiotherapy in post-mastectomy breast cancer patients. Journal of Cancer Therapy 2018;9(11):941-54.   

Deantonio L, Gambaro G, Beldì D, et al. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Radiation oncology (London, England) 2010;5:112.    

Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. The New England Journal of Medicine 2015;373(4):307-16.              

Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment and symptoms. Journal of Clinical Oncology: Official Journal of The American Society of Clinical Oncology 2009;27(3):390-7.